Geneva-based event pledges five Swiss francs per visitor to support new drug development projectLondon, UK, 12 July 2022 / Sciad Newswire / The organisers of Connect in Pharma announce today that for every visitor to the Geneva-based event, five Swiss francs will be donated to EspeRare Foundation, a not-for-profit o.
Cambridge and Stevenage, United Kingdom, 30th June 2022 / Sciad Newswire / NRG Therapeutics Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, and Domainex Ltd., today announce a collaboration focused on developing novel small molecule disease-modifying medicines for the treatment of Parki.
BRIM Biotechnology enters OTC trading in TaiwanTaipei, Taiwan, 23rd June 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TWSE 6995) enters OTC trading in Taiwan on 23rd June 2022, CST. The news was announced at the company’s first earnings call on 22nd June 2022..
Taipei, Taiwan, 23rd June 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TWSE 6995) enters OTC trading in Taiwan on 23rd June 2022, CST. The news was announced at the company’s first earnings call on 22nd June 2022.Established in July 2013, BRIM is a clinical-stage company developing novel regenerative ther.
Image: YewMaker founder and CEO Nazneen RahmanThe Geneva-based inaugural Connect in Pharma event will host an awards ceremony to showcase innovations in sustainable pharmaceutical packagingLondon, UK, 17 June 2012 / Sciad Newswire / YewMaker and Connect in Pharma announce today that the winners of the new Sustainabl.